AGP Executive Report
Last update: 4 hours agoHealthcare Tech & Post-Acute EHR: Frazier Healthcare Partners named Jonathan Lujan CEO of MatrixCare after closing its acquisition from ResMed, aiming to expand cloud EHR and revenue cycle tools for skilled nursing, senior living, home health, hospice, and life plan communities. Branding in Obesity/Diabetes: Novo Nordisk rebranded as “Novo,” rolling out the “Lasting Health Starts Now” platform and a new “Novo Way” culture framework as it pushes into a more competitive obesity and diabetes market. Prior Auth Automation: Optum Rx’s PreCheck Prior Authorization uses data already in a provider’s EHR to automate nearly two-thirds of approved prior authorizations in under 30 seconds, with denials still routed to clinicians. Oncology Survival Update: Final PAPILLON trial results show amivantamab plus chemo delivered about three years of overall survival in EGFR exon 20 NSCLC, with a meaningful survival advantage despite high crossover. Manufacturing Reshuffle: Sanofi agreed to divest three manufacturing sites and a portfolio of 20 mature medicines to Cheplapharm, with transfers planned for 2027. Rare Disease Breakthrough: FDA accepted an sNDA to extend MIUDELLA’s hormone-free IUD use from 3 to up to 6 years, and also granted priority review for zasocitinib in moderate-to-severe plaque psoriasis. Policy & Payments: MGMA urged CMS to drop a proposed 50% same-day payment cut for office visits paired with procedures, warning it could hurt convenient, same-day care. Workforce & Training: Culver-Stockton College won a $1.56M grant to build a permanent nursing facility at Hannibal Regional Hospital, supporting faster RN pathways for rural students. AI in Healthcare Ops: Nara Health raised $14M for an AI-powered third-party administration platform that builds employer health plans and supports claims adjudication and member support.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.